Processa Pharmaceuticals, Inc. Common PCSA

$2.43 -2.80% at last close

Analyst Consensus

Consensus Rating
Buy (1 Buy · 0 Hold · 0 Sell)
Average Price Target
$1.00
Implied Upside
-58.8%
Price Target Range
$1.00 – $1.00
Analysts (12 mo)
1

Recent Analyst Actions

DateFirmActionRatingPrice Target
2025-09-02
HC Wainwright & Co.Raghuram Selvaraju
 Maintains Buy $2 → $1
2025-06-30
HC Wainwright & Co.Raghuram Selvaraju
 Maintains Buy $6 → $2
2024-12-05
HC Wainwright & Co.Raghuram Selvaraju
 Reiterates Buy $6
2024-10-03
HC Wainwright & Co.Raghuram Selvaraju
 Reiterates Buy $6
2024-08-20
HC Wainwright & Co.Raghuram Selvaraju
 Reiterates Buy $6
2024-08-19
HC Wainwright & Co.Raghuram Selvaraju
 Maintains Buy $8 → $6
2024-08-01
HC Wainwright & Co.Raghuram Selvaraju
 Reiterates Buy $8
2024-06-12
HC Wainwright & Co.Raghuram Selvaraju
 Reiterates Buy $8
2024-05-13
HC Wainwright & Co.Raghuram Selvaraju
 Reiterates Buy $8
2024-04-25
HC Wainwright & Co.Raghuram Selvaraju
 Initiates coverage on Buy $8
2024-03-06
BenchmarkRobert Wasserman
 Reiterates Speculative buy $4
2023-11-17
Maxim GroupNaz Rahman
 Downgrades Buy → Hold —
2023-04-04
BenchmarkAydin Huseynov
 Maintains Speculative buy $180 → $80
2023-04-03
OppenheimerFrancois Brisebois
 Maintains Outperform $100 → $60
2023-01-12
Maxim GroupNaz Rahman
 Maintains Buy $180 → $100
2022-04-19
Maxim GroupNaz Rahman
 Initiates coverage on Buy $180
2021-08-03
OppenheimerFrancois Brisebois
 Initiates coverage on Outperform $400
2021-08-02
OppenheimerFrancois Brisebois
 Initiates coverage on Outperform $400
2020-10-28
Craig-Hallum
 Initiates coverage on Buy $240

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$2.43
Market Cap
$8.15 million
52-Week Range
$1.67 – $14.24
Average Volume
451K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.